Diagnostics and research stocks with the fastest revenue growth

Ranked

42

of 74 diagnostics and research stocks we cover

Median

+6.9%

Highest

+90.1%

BLLN

Range

−13.3% to +90.1%

#	Company	Revenue growth	Net margin	Price to sales	Market cap
1	BLLNBillionToOne	+90.1%	9.5%	12.8×	$5.1B
2	CAICaris Life Sciences	+85.4%	10.6%	9.1×	$9B
3	WATWaters	+52.5%	3.6%	9.6×	$44.6B
4	GHGuardant Health	+42.7%	−38.3%	19.2×	$22.7B
5	NTRANatera	+37.8%	−7.1%	21.5×	$58.2B
6	BDSXBiodesix	+34.5%	−27.0%	2.2×	$223.5M
7	CDNACareDx	+34.4%	24.2%	7.8×	$3.6B
8	MEDPMedpace	+24.7%	17.7%	6.7×	$18.7B
9	GRALGRAIL	+23.1%	n/m	35.8×	$5.9B
10	QTRXQuanterix	+22.0%	−80.2%	0.9×	$135.3M
11	XGNExagen	+20.8%	−26.6%	2.5×	$176.1M
12	RDNTRadNet	+18.9%	−0.9%	2.4×	$5.5B
13	VCYTVeracyte	+17.3%	20.4%	6.9×	$3.9B
14	MASS908 Devices	+13.4%	−57.0%	7.8×	$474.9M
15	IDXXIDEXX Laboratories	+12.8%	25.0%	9.7×	$44.1B
16	NTLAIntellia Therapeutics	+12.6%	n/m	26.4×	$1.6B
17	DGXQuest Diagnostics	+9.1%	9.2%	2.3×	$26.7B
18	AAgilent Technologies	+8.6%	19.5%	6.6×	$48.8B
19	TMOThermo Fisher Scientific	+8.3%	14.9%	5.3×	$249.1B
20	IQVIQVIA	+8.2%	8.1%	2.7×	$46B
21	MTDMettler-Toledo International	+6.9%	21.9%	8.1×	$33.5B
22	FLGTFulgent Genetics	+6.8%	−26.0%	1.7×	$553.1M
23	LHLabcorp	+6.4%	7.0%	1.9×	$26.7B
24	CTKBCytek Biosciences	+5.4%	−39.0%	3.5×	$726.6M
25	ILMNIllumina	+4.9%	18.4%	9.1×	$40.7B
26	DHRDanaher	+4.6%	15.9%	6.5×	$162B
27	RVTYRevvity	+4.1%	8.2%	6.1×	$17.7B
28	CSTLCastle Biosciences	+3.2%	−5.4%	2.8×	$1B
29	LNTHLantheus	+2.3%	17.7%	4.2×	$6.5B
30	PACBPacific Biosciences of California	+2.0%	−82.5%	4.1×	$655.9M
31	BRKRBruker	+1.6%	−2.0%	2.5×	$8.8B
32	BIOBio-Rad Laboratories	+1.4%	8.6%	3.8×	$9.9B
33	NRCNRC Health	−0.2%	4.2%	3.5×	$485.1M
34	NEOGNeogen	−0.3%	−6.3%	3.0×	$2.7B
35	CRLCharles River Laboratories International	−0.7%	−6.0%	4.1×	$16.5B
36	HBIOHarvard Bioscience	−1.1%	−11.9%	0.4×	$37.5M
37	AVTRAvantor	−1.6%	−8.8%	1.8×	$11.7B
38	FTREFortrea	−2.1%	−3.2%	0.8×	$2.2B
39	QDELQuidelOrtho	−2.5%	−39.2%	0.4×	$941.5M
40	MYGNMyriad Genetics	−3.2%	−14.0%	0.7×	$556.7M
41	TXG10x Genomics	−4.3%	−12.2%	15.1×	$9.3B
42	PSNLPersonalis	−13.3%	n/m	24.3×	$1.7B

Not ranked: 23 with under $50M of revenue, 4 with not a meaningful number, 2 with a quarter missing. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.